Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-23

Clinical Trial Update: Study of Atropine Therapeutic Effect on Myopic Progression [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating atropine's therapeutic effect on myopic progression in children; status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atropine (unspecified formulation) (atropine)

Snippet

Sponsor: LitePharmTech Co., Ltd. | Conditions: Myopia, Children | Phase 3 | Status: UNKNOWN